Product development
& formulation
Commission product development from Avoria GmbH - from the first briefing through formulation development and pilot batch to the stability study. Direct manufacturer in Roßtal, Bavaria. ISO 9001 & HACCP certified, since 2010.
Quick answer
Product development
at a glance
Avoria GmbH handles the entire product development - from the first briefing through formulation development and pilot batch to the stability study and series handover. Development and production run at the same site in Roßtal, Bavaria, without outsourcing. ISO 9001 and HACCP certified, since 2010.
Note: this offering is aimed exclusively at commercial clients. Avoria GmbH does not provide legal or regulatory advice.
- ISO 9001 & HACCP certified direct manufacturer - development and production at the same site in Roßtal, Bavaria, without outsourcing.
- Own GC-MS/MS laboratory in Roßtal - raw material verification and analytics directly within the development process, no external waiting times.
- 6 product categories - cosmetics, hygiene, CBD, flavorings, e-liquids and chemicals, with regulatory aspects integrated from the start.
What we offer
Our developmentcompetencies
Individual formulation development
Tailor-made formulations - from concept idea to production-ready formulation.
In-house laboratory
In-house laboratory for daily testing, fast iterations and immediate adjustments.
Stability testing
Shelf-life testing under accelerated conditions safeguards long-term stability.
Regulatory guidance
Support with cosmetics law, food law, REACH and other regulations.
Sample production
Prototypes and pilot runs for release - all parameters validated before series start.
Fast turnaround times
Short communication paths enable sample turnarounds of 4 weeks on average.
01 - Development
Your product, rethought
Outsourcing product development to a contract manufacturer means bringing in a development partner who turns a briefing into a validated, producible formulation - and transfers it directly into its own production line. Whether cosmetics (EU 1223/2009), hygiene products (BPR 528/2012), CBD, flavorings or chemicals (REACH/CLP): the in-house GC-MS laboratory enables raw material verification and analytics directly within the development process, without external waiting times. See also: Laboratory analyses & quality testing · Contract filling
From idea to product
Product categories
Categories we develop
From cosmetics to specialty chemicals - our development team covers six regulated product categories at the same site.
Cosmetics
Formulations under the EU Cosmetics Regulation 1223/2009 - creams, serums, shampoos, gels and more. PIF documentation and CPNP notification included.
More about cosmetics →
Hygiene products & disinfectants
Biocide-compliant development under BPR 528/2012 (product types PT1, PT2, PT4). Efficacy evidence per EN standards, approval documents and safety data sheets.
More about hygiene products & disinfectants →
CBD formulations & specialty preparations
CBD oils, capsules, creams and isolates with GC-MS-verified THC content <0.2%. Novel-food-compliant processes and complete CoA documentation.
More about CBD formulations & specialty preparations →
Flavorings & flavor drops
Food flavorings under Regulation (EC) 1334/2008 as well as flavor drops for water, sports drinks and functional food. Declaration-compliant formulations, allergen-tested.
More about flavorings & flavor drops →
E-liquids
Nicotine-containing and nicotine-free e-liquids under TPD 2014/40/EU. Batch-accurate GC-MS analysis, ECID registration and legally compliant labeling for DACH and the EU.
More about e-liquids →
Chemicals under REACH & CLP
Development and filling of propylene glycol, glycerin, ethanol and specialty chemicals. REACH-compliant SDS creation, CLP labeling and ADR-compliant packaging.
More about chemicals under REACH & CLP →
Our process
From idea to series maturity
Briefing
Written specification: target application, texture, ingredients, packaging format, regulatory category and target market. Nothing goes into the lab before the briefing has been worked through.
Formulation development
Formulation iterations against the briefing. GC-MS verification of incoming raw materials directly in the lab - no external laboratory, no waiting time. Every iteration documented.
Pilot batch
Pilot batch on the actual production line - not in a beaker. Filling speed, viscosity, foaming behavior and container compatibility tested under real conditions.
Stability study
Stability testing confirms shelf life, ingredient compatibility and packaging interaction. For cosmetics, this feeds directly into the safety assessment under EU Regulation 1223/2009.
Series handover
Production parameters fixed and documented. Same site, same line - no technology transfer, no re-induction. Complete documentation from the first lab iteration to series release.
Request project quote
Product development – inquire now
Describe your product idea - the more details, the faster we arrive at an honest assessment.
FAQ
Frequently asked questions
The key answers on product development - quick and direct.
Sometimes a short call is faster than any form.
Call now →Avoria GmbH develops formulations for six product categories: cosmetics, hygiene products and disinfectants, CBD preparations, flavorings and flavor drops, e-liquids, and chemicals and specialty formulations under REACH/CLP. Each category brings different regulatory requirements - from the EU Cosmetics Regulation 1223/2009 through the Biocidal Products Regulation BPR 528/2012 to REACH - which are integrated into the development process from the start.
No - both routes are possible. If you bring your own formulation, Avoria GmbH qualifies it against your specification and tests it for production compatibility in a pilot batch. If you start without an existing formulation, you receive complete formulation development based on the product briefing - including raw material selection, lab iterations and stability testing. Both lead to the same series handover.
Avoria GmbH integrates the regulatory framework into the development process from the start - not as a downstream check. For cosmetics, this means GMP documentation per ISO 22716 and analytical data for the safety assessment under EU Regulation 1223/2009. For biocides, the EU Biocidal Products Regulation BPR 528/2012 applies. For chemicals, REACH and CLP requirements including safety data sheets are covered. The documentation - batch records, stability data, analysis results - is handed over in full.
Development costs vary widely by product category, formulation complexity and the number of pilot iterations required. For uncomplicated formulations, the pilot phase typically involves a flat development fee covering lab work, raw material procurement and QA documentation. Complex formulations with stability requirements or novel ingredients require more iterations - costs are calculated per project after the briefing.
The timeframe depends on the starting point and the regulatory category. An uncomplicated cosmetic formulation from briefing to pilot batch takes 4–8 weeks. Stability testing adds another 4–12 weeks depending on the target shelf life. For products with complex regulatory requirements - CBD, biocides, specialty chemicals - additional time for regulatory review should be planned. We communicate timeframes clearly in the briefing.
Once a formulation has completed the stability study and QA release has been granted, production parameters are fixed in a production specification document. The pilot batch data flows directly into the first series order - no re-induction, no re-testing of known parameters. Development and contract filling run at the same site: the audit trail is continuous, from the first lab iteration to final release.
More services